{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-139069","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.493052+00:00","generated_at":"2026-06-26T00:54:19.878018+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tarsus prices upsized $75.6M public offering of 5.6M shares at $13.50/share","bullets":["Priced 5,600,000 shares of common stock at $13.50 per share for gross proceeds of $75.6M.","Underwriters granted 30-day option to purchase up to 840,000 additional shares.","Net proceeds expected to be ~$70.6M after underwriting discounts and expenses.","Offering led by BofA Securities, Jefferies, Barclays, and Raymond James as joint book-runners.","Closing expected on May 5, 2022, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-139069","json":"https://secwatch.observer/filing/0001193125-22-139069.json","markdown":"https://secwatch.observer/filing/0001193125-22-139069.md","text":"https://secwatch.observer/filing/0001193125-22-139069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000119312522139069/0001193125-22-139069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000119312522139069/d333422d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:54:19.878018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}